Dysregulated myelopoiesis is identified as a driver of nutritionally acquired immunodeficiency that persists after refeeding and nutritional recovery, indicating exposure to food scarcity may be an ...

Clonal hematopoiesis is common and associated with adverse outcomes, particularly in patients with cancer. Although conventional cytotoxic therapies are known to drive clonal hematopoiesis, ...